Am J Psychiatry 163:1898-1904, November 2006
doi: 10.1176/appi.ajp.163.11.1898
© 2006 American Psychiatric Association
The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide
Robert D. Gibbons, Ph.D.,
Kwan Hur, Ph.D.,
Dulal K. Bhaumik, Ph.D., and
J. John Mann, M.D.
OBJECTIVE: In 2002, 264 children and adolescents ages 5–14 died by suicide in the United States, the fifth leading cause of death. Of these suicides, 260 were in the 10–14 year age group, making suicide the third largest cause of death behind accidents and malignancy. Although 60% of suicides in the general population occur in the midst of a mood disorder, usually untreated, little is known about the relationship between treatment of mood disorders and youth suicide. The FDA recently linked adverse event reports of suicidal ideation among children and adolescents in randomized controlled trials to selective serotonin reuptake inhibitors (SSRIs) and consequently required a change in labeling that included a black box warning regarding SSRI use for all age groups. Given that the age-adjusted suicide rate is about six times higher in 15–19 year olds compared with 10–14 year olds, the risk-benefit ratio may be different in younger children. Therefore, this study examined the association between antidepressant medication prescription rate and suicide rate in children ages 5–14 prior to the FDA findings by analyzing associations at the county level across the United States. METHOD: National county-level suicide rate data among children ages 5–14 were broken down by sex, income, and race during the period 1996–1998. National county-level antidepressant prescription rate data were expressed as number of pills prescribed per person. The primary outcome measure was the suicide rate in each county expressed as number of suicides for a given population size. RESULTS: After adjustment for sex, race, income, access to mental health care, and county-to-county variability in suicide rates, higher SSRI prescription rates were associated with lower suicide rates in children and adolescents. CONCLUSIONS: The aggregate nature of these observational data precludes a direct causal interpretation of the results. More SSRI prescriptions are associated with lower suicide rates in children and may reflect antidepressant efficacy, treatment compliance, better quality mental health care, and low toxicity in the event of a suicide attempt by overdose.
Related Article:
-
In This Issue
Am J Psychiatry 2006 163: A66.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
A. M. Libby, H. D. Orton, and R. J. Valuck
Persisting Decline in Depression Treatment After FDA Warnings
Arch Gen Psychiatry,
June 1, 2009;
66(6):
633 - 639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gibbons PhD and J. J. Mann MD
Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression
Can. Med. Assoc. J.,
February 3, 2009;
180(3):
270 - 271.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Barbui MD, E. Esposito MD, and A. Cipriani MD
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
Can. Med. Assoc. J.,
February 3, 2009;
180(3):
291 - 297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Nock, G. Borges, E. J. Bromet, C. B. Cha, R. C. Kessler, and S. Lee
Suicide and Suicidal Behavior
Epidemiol. Rev.,
November 1, 2008;
30(1):
133 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
Focus,
July 1, 2008;
6(3):
379 - 400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Morgan, C. Griffiths, and A. Majeed
Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004
J Public Health,
March 1, 2008;
30(1):
60 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon and J. Savarino
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Focus,
January 1, 2008;
6(1):
80 - 85.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. James
Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY
Adv. Psychiatr. Treat.,
January 1, 2008;
14(1):
10 - 16.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. GIBBONS
Dr. Gibbons Replies
Am J Psychiatry,
December 1, 2007;
164(12):
1908 - 1910.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Cheung, R. A. Zuckerbrot, P. S. Jensen, K. Ghalib, D. Laraque, R. E.K. Stein, and and the GLAD-PC Steering Group
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management
Pediatrics,
November 1, 2007;
120(5):
e1313 - e1326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Leckman and R. A. King
A Developmental Perspective on the Controversy Surrounding the Use of SSRIs to Treat Pediatric Depression
Am J Psychiatry,
September 1, 2007;
164(9):
1304 - 1306.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Gibbons, C. H. Brown, K. Hur, S. M. Marcus, D. K. Bhaumik, J. A. Erkens, R. M.C. Herings, and J. J. Mann
Early Evidence on the Effects of Regulators' Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents
Am J Psychiatry,
September 1, 2007;
164(9):
1356 - 1363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Szanto, S. Kalmar, H. Hendin, Z. Rihmer, and J. J. Mann
A Suicide Prevention Program in a Region With a Very High Suicide Rate
Arch Gen Psychiatry,
August 1, 2007;
64(8):
914 - 920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon and J. Savarino
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Am J Psychiatry,
July 1, 2007;
164(7):
1029 - 1034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Gibbons, C. H. Brown, K. Hur, S. M. Marcus, D. K. Bhaumik, and J. J. Mann
Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets
Am J Psychiatry,
July 1, 2007;
164(7):
1044 - 1049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Friedman and A. C. Leon
Expanding the Black Box -- Depression, Antidepressants, and the Risk of Suicide
N. Engl. J. Med.,
June 7, 2007;
356(23):
2343 - 2346.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Pfeffer
The FDA Pediatric Advisories and Changes in Diagnosis and Treatment of Pediatric Depression
Am J Psychiatry,
June 1, 2007;
164(6):
843 - 846.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Libby, D. A. Brent, E. H. Morrato, H. D. Orton, R. Allen, and R. J. Valuck
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
Am J Psychiatry,
June 1, 2007;
164(6):
884 - 891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Dhanikula, D. Lamontagne, and J.-C. Leroux
Rescue of amitriptyline-intoxicated hearts with nanosized vesicles
Cardiovasc Res,
June 1, 2007;
74(3):
480 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon
The Antidepressant Quandary -- Considering Suicide Risk When Treating Adolescent Depression
N. Engl. J. Med.,
December 28, 2006;
355(26):
2722 - 2723.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
